[
  {
    "ts": null,
    "headline": "Regeneron: Strong R&D Pipeline Drives Growth Outlook",
    "summary": "Regeneron remains a 'Strong Buy' amid investor concerns and strong drug performances. Read here for more financial analysis of REGN stock.",
    "url": "https://finnhub.io/api/news?id=3d4ba0704f1a3d97b6cda52ebfecc661b38899c3e02c095bd67bce24888f884c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758963632,
      "headline": "Regeneron: Strong R&D Pipeline Drives Growth Outlook",
      "id": 136900904,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/904246150/image_904246150.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Regeneron remains a 'Strong Buy' amid investor concerns and strong drug performances. Read here for more financial analysis of REGN stock.",
      "url": "https://finnhub.io/api/news?id=3d4ba0704f1a3d97b6cda52ebfecc661b38899c3e02c095bd67bce24888f884c"
    }
  }
]